Join Our Newsletter

TooNiceStocks Wow the bids are so huge at $38 $FB is calling for help from all the big boys. $FB once $38 falls blood on the street, thinning out at $38!
9 hours 57 min ago
TooNiceStocks NASDAQ: $FB loving the bounce on this baby! Lets gooooooooo! We said dumping then bounce hehehheheh love it
13 hours 35 min ago
TooNiceStocks $FB boucning up $.60 so far from $38 to $38.60! LOL
13 hours 54 min ago
TooNiceStocks Like we said there goes the DUMPING on NASDAQ: $FB let them dump away so we can bounce you $FB, dump dump dump the big boys loaded at $38!
13 hours 59 min ago
TooNiceStocks in other news our $TVIX has been ripping up 6 days in a row and from $6 to $10.30 now, so freaking bullish, SUMMER SHORT PLAY getting JIGGY!
14 hours 1 min ago

Follow TooNice on Twiter

TooNiceStocks Watchlist

Symbol	Last	Change
YMI	1.98	-4.59
AEN	0.00	0.00
CORT	3.94	-0.24
CRMD	0.23	-11.54
NEOP	2.76	0.00
GNTA.OB	0.00	0.00
IGXT.OB	0.49	1.03
ACUR	2.68	-1.47
TLON	0.00	0.00
ADXS.OB	0.10	-0.95
RAS	4.05	1.00
HGSI	14.12	-0.95
LNG	14.30	-7.32
UEC	2.30	2.22

Choose Language

See your Ad here!
Contact us for details.

SOMX - Somaxon Pharmaceuticals, Inc.

Login or register to post comments

Date:

Tue, 12/08/2009

TNS members were alerted to Nasdaq Exchange Traded SOMX at $1.15 on the bounce play after the U.S. Food and Drug Administration (FDA) determined that the New Drug Application (NDA) could not be approved in its present form for Silenor for the treatment of insomnia. SOMX closed at $1.41 and at one point during the day reaching $1.53, an intraday trade that would have yielded 33% ROI.

TooNiceStocks.com was not compensated, rather we have initiated our own independent research. As always read full disclaimer

Copyright© 2009 TooNiceStocks All rights reserved.

No portion of TooNiceStocks.com may be duplicated, redistributed or manipulated in any form, violators will be prosecuted to the full extent of the law.
By accessing any information beyond this page, you agree to abide by the Privacy Policy and Terms of Use (Disclaimer).

TooNiceStocks.com is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities customers should buy or sell for themselves. The analysts and employees or affiliates of TooNiceStocks.com may hold positions in the stocks or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities. TooNiceStocks.com, the authors, the publisher, and all affiliates of TooNiceStocks.com assume no responsibility or liability for your trading and investment results. Factual statements on TooNiceStocks.com, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by TooNiceStocks.com are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of TooNiceStocks.com are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on TooNiceStocks.com are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

Join our Free Newsletter!